Langenfeld, Germany

Klaus Sandrock


Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1981-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Klaus Sandrock: Driving Pharmaceutical Innovations

Introduction:

In the dynamic realm of pharmaceutical innovations, inventors play a pivotal role in the development of groundbreaking solutions. One such exceptional innovator is Klaus Sandrock, a prolific inventor from Langenfeld, Germany. With an impressive portfolio of five patents and a career marked by valuable collaborations, Sandrock has consistently contributed to advancing the field of pharmaceuticals.

Latest Patents:

Sandrock's recent patents demonstrate his expertise in enhancing drug delivery systems. His groundbreaking invention, "Pharmaceutical compositions containing 1-oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes," focuses on topical applications of pharmaceutical compositions using 1-oleylazacycloheptan-2-one. This compound effectively improves epithelial membrane permeability in humans and animals, allowing for more effective delivery of physiologically active agents.

Another notable patent of Sandrock's encompasses "Organic nitrates containing a disulfide group as cardiovascular agents." This innovation presents novel solutions for cardiovascular treatments, highlighting Sandrock's contributions to therapeutic advancements in this critical medical domain.

Career Highlights:

Throughout his career, Klaus Sandrock has been associated with renowned companies that have facilitated his innovative contributions. He has contributed significantly to Schwarz Pharma AG and Sanol Schwarz-Monheim GmbH, two leading pharmaceutical companies at the forefront of groundbreaking research and drug development.

Collaborations:

Innovation often thrives through collaboration, and Sandrock's successful partnerships have amplified his contributions. Among his esteemed coworkers are Eike Noack and Martin Feelisch. These collaborations have enabled Sandrock to work alongside like-minded individuals, pooling their expertise to drive pharmaceutical advancements.

Conclusion:

Klaus Sandrock's dedication and expertise in pharmaceutical innovations have been instrumental in revolutionizing drug delivery methodologies and cardiovascular treatments. With an impressive repertoire of patents and invaluable collaborations, Sandrock continues to inspire future inventors and actively contributes to the growth and development of the pharmaceutical industry.

Please note that the information provided is based on the given data, and additional research may enhance the details surrounding Klaus Sandrock's accomplishments and contributions to the field of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…